Literature DB >> 33284849

Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles.

Akshamal M Gamage1, Kai Sen Tan2, Wharton O Y Chan1, Jing Liu2, Chee Wah Tan1, Yew Kwang Ong3, Mark Thong3, Anand K Andiappan4, Danielle E Anderson1, De Yun Wang2, Lin-Fa Wang1,5.   

Abstract

The novel coronavirus SARS-CoV-2 is the causative agent of Coronavirus Disease 2019 (COVID-19), a global healthcare and economic catastrophe. Understanding of the host immune response to SARS-CoV-2 is still in its infancy. A 382-nt deletion strain lacking ORF8 (Δ382 herein) was isolated in Singapore in March 2020. Infection with Δ382 was associated with less severe disease in patients, compared to infection with wild-type SARS-CoV-2. Here, we established Nasal Epithelial cells (NECs) differentiated from healthy nasal-tissue derived stem cells as a suitable model for the ex-vivo study of SARS-CoV-2 mediated pathogenesis. Infection of NECs with either SARS-CoV-2 or Δ382 resulted in virus particles released exclusively from the apical side, with similar replication kinetics. Screening of a panel of 49 cytokines for basolateral secretion from infected NECs identified CXCL10 as the only cytokine significantly induced upon infection, at comparable levels in both wild-type and Δ382 infected cells. Transcriptome analysis revealed the temporal up-regulation of distinct gene subsets during infection, with anti-viral signaling pathways only detected at late time-points (72 hours post-infection, hpi). This immune response to SARS-CoV-2 was significantly attenuated when compared to infection with an influenza strain, H3N2, which elicited an inflammatory response within 8 hpi, and a greater magnitude of anti-viral gene up-regulation at late time-points. Remarkably, Δ382 induced a host transcriptional response nearly identical to that of wild-type SARS-CoV-2 at every post-infection time-point examined. In accordance with previous results, Δ382 infected cells showed an absence of transcripts mapping to ORF8, and conserved expression of other SARS-CoV-2 genes. Our findings shed light on the airway epithelial response to SARS-CoV-2 infection, and demonstrate a non-essential role for ORF8 in modulating host gene expression and cytokine production from infected cells.

Entities:  

Year:  2020        PMID: 33284849     DOI: 10.1371/journal.ppat.1009130

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  34 in total

1.  Human Nasal Epithelial Cells (hNECs ) Generated by Air-Liquid Interface (ALI) Culture as a Model System for Studying the Pathogenesis of SARS-CoV-2.

Authors:  Kai Sen Tan; Akshamal M Gamage; Jing Liu
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19.

Authors:  James P Bridges; Eszter K Vladar; Hua Huang; Robert J Mason
Journal:  Thorax       Date:  2021-08-17       Impact factor: 9.102

3.  The Omicron Variant of the Sars-Cov-2 Virus As the Dominant Agent of a New Risk of Disease amid the COVID-19 Pandemic.

Authors:  G G Onishchenko; T E Sizikova; V N Lebedev; S V Borisevich
Journal:  Her Russ Acad Sci       Date:  2022-09-06       Impact factor: 0.552

4.  HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19.

Authors:  Chiara Ripamonti; Valeria Spadotto; Pietro Pozzi; Andrea Stevenazzi; Barbara Vergani; Mattia Marchini; Giovanni Sandrone; Emanuele Bonetti; Luca Mazzarella; Saverio Minucci; Christian Steinkühler; Gianluca Fossati
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

5.  Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1.

Authors:  Sejal Saglani; Clare M Lloyd; Helen Stölting; Laury Baillon; Rebecca Frise; Katie Bonner; Richard J Hewitt; Philip L Molyneaux; Mindy L Gore; Wendy S Barclay
Journal:  Mucosal Immunol       Date:  2022-07-15       Impact factor: 8.701

Review 6.  Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats.

Authors:  Sahana Nagaraja; Disha Jain; Sannula Kesavardhana
Journal:  J Leukoc Biol       Date:  2021-05-31       Impact factor: 6.011

Review 7.  SARS-CoV-2 one year on: evidence for ongoing viral adaptation.

Authors:  Thomas P Peacock; Rebekah Penrice-Randal; Julian A Hiscox; Wendy S Barclay
Journal:  J Gen Virol       Date:  2021-04       Impact factor: 3.891

8.  Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes.

Authors:  Anshika Sharma; Joe W Ong; Mun Fai Loke; Eng Guan Chua; Joseph J Lee; Hyung Won Choi; Yee Joo Tan; Sunil K Lal; Vincent T Chow
Journal:  Microorganisms       Date:  2021-05-31

9.  Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.

Authors:  Daniel Reynolds; Cristina Vazquez Guillamet; Aaron Day; Nicholas Borcherding; Rodrigo Vazquez Guillamet; José Alberto Choreño-Parra; Stacey L House; Jane A O'Halloran; Joaquín Zúñiga; Ali H Ellebedy; Derek E Byers; Philip A Mudd
Journal:  J Immunol       Date:  2021-08-04       Impact factor: 5.426

Review 10.  Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.

Authors:  Ahmed S Abdel-Moneim; Elsayed M Abdelwhab; Ziad A Memish
Journal:  Virology       Date:  2021-02-22       Impact factor: 3.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.